Boston Scientific Corp. Stock Slides 5.1%, Underperforms Peers
Dow Jones2026/08/20 20:34This article was automatically generated by Dow Jones using technology from Automated Insights.
Shares of Boston Scientific Corp. slid 5.1% to $49.37 on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index falling 0.9% to 7,641.16 and Dow Jones Industrial Average falling 1.3% to 52,759.21.
Boston Scientific Corp. closed 54.9% short of its 52-week high of $109.50, which the company reached on September 9th.
The stock underperformed when compared to some of its peers, as Abbott Laboratories fell 0.3% to $114.14, Medtronic PLC fell 1.9% to $92.30, and Stryker Corp. fell 3.61% to $327.70.
Trading volume totaled 20.4 million, compared to the 50-day average of 19.6 million.
Data source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
August 20, 2026 16:34 ET (20:34 GMT)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Tesla (TSLA.US) drops over 10% in a week, but ARK keeps buying! Cathie Wood: This is the moment we've been waiting for
Despite the recent volatility in Tesla's stock price, ARK Invest founder Cathie Wood, known as the "Goddess of Wall Street," remains optimistic about the company.

U.S. stock futures fluctuate by $650 billions due to news related to Jensen Huang

Nikkei Average Index gains expand to 2.78%
